Google’s AMIE studied in single-center primary-care trial
Researchers from Google and Beth Israel Deaconess Medical Center studied AMIE, an AI system that conversed with patients before urgent primary-care appointments. The prospective feasibility study enrolled 114 patients at BIDMC; 98 completed both the AI interaction and their appointment.

Key takeaways · 4
- 01
The study enrolled 114 patients, and 98 completed both the AMIE interaction and their appointment.
- 02
A physician monitored every AMIE conversation in real time.
- 03
Providers found AMIE helpful in preparing for 33 of 44 visits where they reviewed its transcript beforehand.
- 04
The study was designed to assess feasibility, not whether AI improves health outcomes.
A monitored pre-visit conversation
AMIE stands for Articulate Medical Intelligence Explorer.[1] In the study, English-speaking adults used it before an urgent primary-care appointment for a single complaint.[1] The system asked about symptoms and medical history, suggested possible diagnoses to discuss with a physician, and generated a clinician summary before the visit.[3] A physician monitored each conversation in real time.[3] The work took place at BIDMC’s ambulatory primary-care clinic.[2] For health teams, this setup is an important boundary: the system was tested as preparation for a clinician visit, not as an unmonitored substitute for one.
Promising ratings, with mixed results
Clinical evaluators rated AMIE’s conversations favorably in 87% to 100% of cases across 17 criteria; patients gave favorable ratings in 48% to 96% of cases across 16 criteria.[1] AMIE’s differential diagnosis included the final diagnosis in 90% of cases, and its diagnostic accuracy among its top three possibilities was 75%.[4] The comparison found no significant difference in differential-diagnosis quality, while primary-care providers outperformed AMIE on the practicality and cost-effectiveness of management plans.[4] These findings point to different performance across tasks, rather than a single measure of clinical readiness.
Feasibility is not an outcomes trial
No interaction met the study’s predefined criteria for a safety stop, but safety supervisors noted one hallucination and added clinical information in five interactions.[1] In one case, a physician reported possible harm because a patient may have become anxious after AMIE listed lymphoma as a possible diagnosis.[3] Patients’ attitudes toward AI improved after interacting with AMIE and remained elevated after their physician visit.[1] Providers said the system helped them prepare for 33 of the 44 visits where they reviewed its transcript beforehand, and might have changed their behavior in 25 of those visits.[1] The researchers designed the study to assess feasibility, not health outcomes; Google says larger clinical trials are needed to assess patient-facing AI at scale.[3][2]
For healthcare teams, the results offer evidence about how a patient-facing AI might fit into visit preparation, alongside signals that clinician oversight and review remain important. The feasibility study does not establish that using AMIE improves health outcomes, so teams should distinguish promising workflow findings from evidence of clinical benefit.
Why it matters
Put this to work — one session a day, built for your industry.
Create a free account for a daily session — eight questions and one real-work challenge, on the news that affects your role.
Start freeHow this developed
10 October 2026
Google’s AMIE studied in single-center primary-care trial
Sources
- Conversational diagnostic artificial intelligence in ambulatory primary care: a prospective feasibility study - The Lancetthelancet.com
- Study: AI could improve patient-physician relationshipsblog.google
- How an AI chatbot performed in pre-visit primary care interviews: 6 notesbeckershospitalreview.com
- A prospective clinical feasibility studyof a conversational diagnostic AI inan ambulatory primary care clinicarxiv.org